Current NDC auxiliary source row compounder:2137

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 72627-2406
Product Ndc: 72627-2406
Product Ndc Digits: 726272406
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Alpha-Lipoic Acid
Proprietary Name Suffix: [empty]
Nonproprietary Name: Alpha-Lipoic Acid
Dosage Form Name: INJECTION
Route Name: INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Empower Pharma
Establishment Name: Empower Pharma
Establishment Fei: [empty]
Substance Name: ALPHA LIPOIC ACID
Active Ingredients Info: 25 mg/1 mL
History Active Ingredients Raw: ALPHA LIPOIC ACID
History Active Ingredients Info Raw: 25 mg/1 mL
History Dosage Raw: INJECTION
Dea Schedule: [empty]
Package Ndc Raw: 72627-2406-1
Package Ndc: 72627-2406-1
Package Ndc Digits: 7262724061
Package Ndc11: 72627240601
Package Description: 30 mL in 1 VIAL, MULTI-DOSE (72627-2406-1)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:2137
Source Row Number: 2137
Source Row Hash: a48df5f5213f221625726f5fa69e2c4591ceb2510bae84e5980c74bcb5e89ba7
Import Run Id: 20261024T140201Z
Loaded At: 2026-10-24 14:07:01

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS",
    "PRODUCTNDC": "72627-2406",
    "DEASCHEDULE": "",
    "LABELERNAME": "Empower Pharma",
    "SUBSTANCENAME": "ALPHA LIPOIC ACID",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "72627-2406-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Alpha-Lipoic Acid",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "Alpha-Lipoic Acid",
    "PACKAGEDESCRIPTION": "30 mL in 1 VIAL, MULTI-DOSE (72627-2406-1) ",
    "ACTIVEINGREDIENTSINFO": "25 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:2137
Source Row Number: 2137
Status Scope: package
Lookup Ndc: 72627-2406-1
Lookup Ndc Digits: 7262724061
Product Ndc: 72627-2406
Product Ndc Digits: 726272406
Package Ndc: 72627-2406-1
Package Ndc Digits: 7262724061
Package Ndc11: 72627240601
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: a48df5f5213f221625726f5fa69e2c4591ceb2510bae84e5980c74bcb5e89ba7
Import Run Id: 20261024T140201Z
Loaded At: 2026-10-24 14:07:01